Dicerna Pharmaceuticals reported $8K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acceleron Pharma XLRN:US $ 0.06M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.2M 0.01M
Amgen AMGN:US $ 31989M 112M
Biogen BIIB:US $ 0.1M 0M
Bluebird Bio BLUE:US $ 0.7M 0.02M
Dicerna Pharmaceuticals DRNA:US $ 0.01M 0M
Exelixis EXEL:US $ 0.32M 0M
GlaxoSmithKline GSK:LN 1347M 0M
Intrexon XON:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Macrogenics MGNX:US $ 0.61M 0.01M
Mirati Therapeutics MRTX:US $ 0.05M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M